Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Suzanne Lentzch"'
Autor:
Carlos Fernández de Larrea, Robert Kyle, Laura Rosiñol, Bruno Paiva, Monika Engelhardt, Saad Usmani, Jo Caers, Wilson Gonsalves, Fredrik Schjesvold, Giampaolo Merlini, Suzanne Lentzch, Enrique Ocio, Laurent Garderet, Philippe Moreau, Pieter Sonneveld, Ashraf Badros, Gösta Gahrton, Hartmut Goldschmidt, Sascha Tuchman, Hermann Einsele, Brian Durie, Baldeep Wirk, Pellegrino Musto, Patrick Hayden, Martin Kaiser, Jesús San Miguel, Joan Bladé, S. Vincent Rajkumar, Maria Victoria Mateos
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 12, Pp 1-5 (2021)
Abstract Primary plasma cell leukemia (PCL) has a consistently ominous prognosis, even after progress in the last decades. PCL deserves a prompt identification to start the most effective treatment for this ultra-high-risk disease. The aim of this po
Externí odkaz:
https://doaj.org/article/316690c0ce52472eb67f8eef3f9e74a5
Autor:
Martin Kaiser, Baldeep Wirk, Monika Engelhardt, Bruno Paiva, Laurent Garderet, S. Vincent Rajkumar, Maria-Victoria Mateos, Philippe Moreau, Carlos Fernández de Larrea, Robert A. Kyle, Jo Caers, Wilson I. Gonsalves, Hermann Einsele, Hartmut Goldschmidt, Giampaolo Merlini, Suzanne Lentzch, Ashraf Badros, Saad Z. Usmani, Joan Bladé, Pellegrino Musto, Fredrik Schjesvold, Pieter Sonneveld, Jesús F. San Miguel, Laura Rosiñol, Gösta Gahrton, Patrick Hayden, Enrique M. Ocio, Brian G.M. Durie, Sascha A. Tuchman
Publikováno v:
Blood Cancer J . 2021 Dec 2;11(12):192
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
Blood Cancer Journal
Blood Cancer Journal, Nature Publishing Group, 2021, 11 (12), ⟨10.1038/s41408-021-00587-0⟩
Blood Cancer Journal, Vol 11, Iss 12, Pp 1-5 (2021)
Digital.CSIC. Repositorio Institucional del CSIC
instname
Blood Cancer Journal, 11(12):192. Nature Publishing Group
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
Blood Cancer Journal
Blood Cancer Journal, Nature Publishing Group, 2021, 11 (12), ⟨10.1038/s41408-021-00587-0⟩
Blood Cancer Journal, Vol 11, Iss 12, Pp 1-5 (2021)
Digital.CSIC. Repositorio Institucional del CSIC
instname
Blood Cancer Journal, 11(12):192. Nature Publishing Group
Primary plasma cell leukemia (PCL) has a consistently ominous prognosis, even after progress in the last decades. PCL deserves a prompt identification to start the most effective treatment for this ultra-high-risk disease. The aim of this position pa
Autor:
David A. Siegel, Ajai Chari, Luciano J. Costa, Charise Gleason, Ajay K. Nooka, Joseph Mikhael, Paul G. Richardson, Beth Faiman, Sundar Jagannath, Suzanne Lentzch, Kimberly Noonan
Publikováno v:
Clinical lymphoma, myelomaleukemia. 20(6)
Multiple myeloma patients have seen an unprecedented improved survival in the last decade, primarily due to the introduction of three novel classes of anti-myeloma drugs (proteasome inhibitors, immunomodulatory agents and monoclonal antibodies) and t